{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:48:55Z","timestamp":1785408535260,"version":"3.56.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"1","funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["18H02645"],"award-info":[{"award-number":["18H02645"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["18K16103"],"award-info":[{"award-number":["18K16103"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["15K09645"],"award-info":[{"award-number":["15K09645"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["18H02835"],"award-info":[{"award-number":["18H02835"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19lm0203005"],"award-info":[{"award-number":["JP19lm0203005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16cm0106525h0001"],"award-info":[{"award-number":["16cm0106525h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ck0106331"],"award-info":[{"award-number":["JP19ck0106331"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ck0106253"],"award-info":[{"award-number":["JP19ck0106253"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","award":["11-24307"],"award-info":[{"award-number":["11-24307"]}],"id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The cellular context that integrates gene expression, signaling, and metabolism dictates the oncogenic behavior and shapes the treatment responses in distinct cancer types. Although chimeric fusion proteins involving transcription factors (TF) are hallmarks of many types of acute lymphoblastic leukemia (ALL), therapeutically targeting the fusion proteins is a challenge. In this work, we characterize the core regulatory circuitry (CRC; interconnected autoregulatory loops of TFs) of B-ALL involving MEF2D-fusions and identify MEF2D-fusion and SREBF1 TFs as crucial CRC components. By gene silencing and pharmacologic perturbation, we reveal that the CRC integrates the pre-B-cell receptor (BCR) and lipid metabolism to maintain itself and govern malignant phenotypes. Small-molecule inhibitors of pre-BCR signaling and lipid biosynthesis disrupt the CRC and silence the MEF2D fusion in cell culture and show therapeutic efficacy in xenografted mice. Therefore, pharmacologic disruption of CRC presents a potential therapeutic strategy to target fusion protein\u2013driven leukemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Cancer type\u2013specific gene expression is governed by transcription factors involved in a highly interconnected autoregulatory loop called CRC. Here, we characterized fusion protein\u2013driven CRC and identified its pharmacologic vulnerabilities, opening therapeutic avenues to indirectly target fusion-driven leukemia by disrupting its CRC.<\/jats:p>\n                    <jats:p>See related commentary by Sadras and M\u00fcschen, p. 18.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 5<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-19-0080","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T14:32:20Z","timestamp":1591799540000},"page":"82-95","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia"],"prefix":"10.1158","volume":"1","author":[{"given":"Shinobu","family":"Tsuzuki","sequence":"first","affiliation":[{"name":"1Department of Biochemistry, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Yasuda","sequence":"additional","affiliation":[{"name":"2Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kojima","sequence":"additional","affiliation":[{"name":"3Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-3629","authenticated-orcid":false,"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[{"name":"3Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Akahane","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inukai","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masue","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"5Miyagi Children's Hospital, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Morishita","sequence":"additional","affiliation":[{"name":"6Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Miyamura","sequence":"additional","affiliation":[{"name":"6Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-7298","authenticated-orcid":false,"given":"Toshihide","family":"Ueno","sequence":"additional","affiliation":[{"name":"3Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasundaram","family":"Karnan","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Ota","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Hyodo","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Konishi","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sanada","sequence":"additional","affiliation":[{"name":"2Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[{"name":"2Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[{"name":"2Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tomita","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyogo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Matsumura","sequence":"additional","affiliation":[{"name":"10Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Sayama, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[{"name":"11Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4645-0181","authenticated-orcid":false,"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[{"name":"3Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"12Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"2024012916024727300_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"2024012916024727300_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1101\/gr.197590.115","article-title":"Models of human core transcriptional regulatory circuitries","volume":"26","author":"Saint-Andre","year":"2016","journal-title":"Genome Res"},{"key":"2024012916024727300_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrg3473","article-title":"Mechanisms and models of somatic cell reprogramming","volume":"14","author":"Buganim","year":"2013","journal-title":"Nat Rev Genet"},{"key":"2024012916024727300_bib4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cell.2011.01.032","article-title":"Control of the embryonic stem cell state","volume":"144","author":"Young","year":"2011","journal-title":"Cell"},{"key":"2024012916024727300_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature16546","article-title":"Active medulloblastoma enhancers reveal subgroup-specific cellular origins","volume":"530","author":"Lin","year":"2016","journal-title":"Nature"},{"key":"2024012916024727300_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","article-title":"Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia","volume":"22","author":"Sanda","year":"2012","journal-title":"Cancer Cell"},{"key":"2024012916024727300_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"2024012916024727300_bib8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/ng.3921","article-title":"Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries","volume":"49","author":"Boeva","year":"2017","journal-title":"Nat Genet"},{"key":"2024012916024727300_bib9","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1038\/s41467-018-06699-9","article-title":"TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN\/FOXM1 reactivation of DREAM targets","volume":"9","author":"Decaesteker","year":"2018","journal-title":"Nat Commun"},{"key":"2024012916024727300_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41588-018-0191-z","article-title":"Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry","volume":"50","author":"Durbin","year":"2018","journal-title":"Nat Genet"},{"key":"2024012916024727300_bib11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ccell.2018.11.001","article-title":"Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia","volume":"34","author":"Ott","year":"2018","journal-title":"Cancer Cell"},{"key":"2024012916024727300_bib12","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"key":"2024012916024727300_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2012.01.001","article-title":"The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia","volume":"26","author":"Moorman","year":"2012","journal-title":"Blood Rev"},{"key":"2024012916024727300_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/2159-8290.CD-14-0985","article-title":"Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth","volume":"5","author":"Ran","year":"2015","journal-title":"Cancer Discov"},{"key":"2024012916024727300_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/2159-8290.CD-17-0468","article-title":"FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor","volume":"8","author":"Ran","year":"2018","journal-title":"Cancer Discov"},{"key":"2024012916024727300_bib16","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024012916024727300_bib17","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat Commun"},{"key":"2024012916024727300_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"key":"2024012916024727300_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.2017.186320","article-title":"Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion","volume":"104","author":"Ohki","year":"2019","journal-title":"Haematologica"},{"key":"2024012916024727300_bib20","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2016.66.5547","article-title":"MEF2D-BCL9 fusion gene is associated with high-risk acute B-cell precursor lymphoblastic leukemia in adolescents","volume":"34","author":"Suzuki","year":"2016","journal-title":"J Clin Oncol"},{"key":"2024012916024727300_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat Genet"},{"key":"2024012916024727300_bib22","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.008367","article-title":"MEF2: a central regulator of diverse developmental programs","volume":"134","author":"Potthoff","year":"2007","journal-title":"Development"},{"key":"2024012916024727300_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"2024012916024727300_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng956","article-title":"Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice","volume":"32","author":"Lund","year":"2002","journal-title":"Nat Genet"},{"key":"2024012916024727300_bib25","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2008-05-158196","article-title":"Homing and invasiveness of MLL\/ENL leukemic cells is regulated by MEF2C","volume":"114","author":"Schwieger","year":"2009","journal-title":"Blood"},{"key":"2024012916024727300_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng949","article-title":"New genes involved in cancer identified by retroviral tagging","volume":"32","author":"Suzuki","year":"2002","journal-title":"Nat Genet"},{"key":"2024012916024727300_bib27","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/0008-5472.CAN-13-2171","article-title":"Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes","volume":"74","author":"Ma","year":"2014","journal-title":"Cancer Res"},{"key":"2024012916024727300_bib28","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1007\/s13277-015-4766-3","article-title":"MEF2D\/Wnt\/\u03b2-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19","volume":"37","author":"Xu K","year":"2016","journal-title":"Tumour Biol"},{"key":"2024012916024727300_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"2024012916024727300_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molcel.2015.02.014","article-title":"Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers","volume":"58","author":"Hnisz","year":"2015","journal-title":"Mol Cell"},{"key":"2024012916024727300_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","article-title":"Super-enhancer-driven transcriptional dependencies in cancer","volume":"3","author":"Sengupta","year":"2017","journal-title":"Trends Cancer"},{"key":"2024012916024727300_bib32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"2024012916024727300_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/imr.12235","article-title":"Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia","volume":"263","author":"Buchner","year":"2015","journal-title":"Immunol Rev"},{"key":"2024012916024727300_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"key":"2024012916024727300_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"2024012916024727300_bib36","first-page":"5912","article-title":"Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression","volume":"175","author":"van Zelm","year":"2005","journal-title":"J Immunol Res"},{"key":"2024012916024727300_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2008.02.015","article-title":"Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion","volume":"28","author":"Yasuda","year":"2008","journal-title":"Immunity"},{"key":"2024012916024727300_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"2024012916024727300_bib39","doi-asserted-by":"crossref","first-page":"33271","DOI":"10.1074\/jbc.272.52.33271","article-title":"A dominant-negative form of transcription factor MEF2 inhibits myogenesis","volume":"272","author":"Ornatsky","year":"1997","journal-title":"J Biol Chem"},{"key":"2024012916024727300_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Encode Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2024012916024727300_bib41","doi-asserted-by":"crossref","first-page":"ra60","DOI":"10.1126\/scisignal.2001104","article-title":"The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development","volume":"3","author":"Ramadani","year":"2010","journal-title":"Sci Signal"},{"key":"2024012916024727300_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"2024012916024727300_bib43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","article-title":"Expanding roles for SREBP in metabolism","volume":"16","author":"Shao","year":"2012","journal-title":"Cell Metab"},{"key":"2024012916024727300_bib44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chembiol.2009.07.007","article-title":"A small molecule that blocks fat synthesis by inhibiting the activation of SREBP","volume":"16","author":"Kamisuki","year":"2009","journal-title":"Chem Biol"},{"key":"2024012916024727300_bib45","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1021\/jm200304y","article-title":"Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins","volume":"54","author":"Kamisuki","year":"2011","journal-title":"J Med Chem"},{"key":"2024012916024727300_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","article-title":"Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques","volume":"13","author":"Tang","year":"2011","journal-title":"Cell Metab"},{"key":"2024012916024727300_bib47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat Immunol"},{"key":"2024012916024727300_bib48","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41388-018-0573-9","article-title":"Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity","volume":"38","author":"Hirano","year":"2019","journal-title":"Oncogene"},{"key":"2024012916024727300_bib49","doi-asserted-by":"crossref","first-page":"e1006752","DOI":"10.1371\/journal.pgen.1006752","article-title":"The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness","volume":"13","author":"Di Giorgio","year":"2017","journal-title":"PLoS Genet"},{"key":"2024012916024727300_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","article-title":"BET proteins as targets for anticancer treatment","volume":"8","author":"Stathis","year":"2018","journal-title":"Cancer Discov"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/1\/82\/3411440\/82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/1\/82\/3411440\/82.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T11:04:29Z","timestamp":1706526269000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/1\/1\/82\/35149\/Targeting-MEF2D-fusion-Oncogenic-Transcriptional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":50,"aliases":["10.1158\/2643-3249.bcd-19-0080"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,10]]},"published-print":{"date-parts":[[2020,6,19]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-19-0080","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.6549877.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6549877","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.22542331.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22542328","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22542328.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22542331","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]}}}